257
Views
6
CrossRef citations to date
0
Altmetric
PRESENTED AT THE INTERNATIONAL CONFERENCE ON HEMOGLOBIN DISORDERS, KUWAIT, February 5–7th, 2011

Cerebral Infarction in Children with Sickle Cell Disease: A Concise Overview

, &
Pages 618-624 | Received 15 Jul 2011, Accepted 17 Jul 2011, Published online: 03 Oct 2011

REFERENCES

  • Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031.
  • Verduzco LA, Nathan DG. Sickle cell disease and stroke. Blood. 2009;114(25):5117–5125.
  • Earley CJ, Kittner SJ, Feeser BR, Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;51(1):169–176.
  • Ohene-Frempong K, Weiner SJ, Sleeper LA, Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294.
  • Powars D, Wilson B, Imbus C, Pegelow C, Allen J. The natural history of stroke in sickle cell disease. Am J Med. 1978;65(3):461–471.
  • Scothorn DJ, Price C, Schwartz D, Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;140(3):348–354.
  • Dobson SR, Holden KR, Nietert PJ, Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood. 2002;99(9):3144–3150.
  • Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet. 2001;357(9269):1656–1659.
  • Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120(3):360–366.
  • Adams RJ, Kutlar A, McKie V, α Thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994;45(4):279–282.
  • Switzer JA, Hess DC, Nichols FT, Adams RJ. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006;5(6):501–512.
  • Flanagan JM, Frohlich DM, Howard TA, Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011;117(24):6681–6684.
  • Adams R, McKie V, Nichols F, The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605–610.
  • Adams RJ, McKie VC, Hsu L, Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11.
  • Adams RJ, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005;353(26):2769–7278.
  • Pegelow CH, Adams RJ, McKie V, Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126(6):896–899.
  • Bishop S, Matheus MG, Abboud MR, Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia Blood Cells Mol Dis. 2011;47(2):125–128.
  • Fullerton HJ, Adams RJ, Zhao S, Johnston SC. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004;104(2):336–339.
  • Bernaudin F, Verlhac S, Arnaud C, Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011;117(4):1130–1140; quiz 436.
  • Bernaudin F, Socie G, Kuentz M, Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood. 2007;110(7):2749–5276.
  • Ware RE, Helms RW. Stroke with transfusions changing to hydroxyurea (SWiTCH): a phase 3 randomized clinical trial for treatment of children with sickle cell anemia, previous stroke, and iron overload. Proceeding of the 52nd American Society of Hematology Meeting, Orlando, FL, USA, December 4-7. Blood. 2010;116(21):844.
  • Moser FG, Miller ST, Bello JA, The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996;17(5):965–972.
  • Pegelow CH, Macklin EA, Moser FG, Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99(8):3014–3018.
  • Steen RG, Emudianughe T, Hankins GM, Brain imaging findings in pediatric patients with sickle cell disease. Radiology. 2003;228(1):216–225.
  • Kwiatkowski JL, Zimmerman RA, Pollock AN, Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146(3):300–305.
  • Pegelow CH, Wang W, Granger S, Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001;58(12):2017–2021.
  • Abboud MR, Yim E, Musallam KM, Adams RJ. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011;118(4):894–898.
  • Adekile AD, Yacoub F, Gupta R, Silent brain infarcts are rare in Kuwaiti children with sickle cell disease and high Hb F. Am J Hematol. 2002;70(3):228–231.
  • Miller ST, Macklin EA, Pegelow CH, Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):385–390.
  • Wang W, Enos L, Gallagher D, Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):391–397.
  • Armstrong FD, Thompson RJ Jr, Wang W, Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97(6, Pt. 1):864–870.
  • Bernaudin F, Verlhac S, Freard F, Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol. 2000;15(5):333–343.
  • Kugler S, Anderson B, Cross D, Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. Arch Neurol. 1993;50(6):629–635.
  • Kinney TR, Sleeper LA, Wang WC, Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999;103(3):640–645.
  • Wang WC, Gallagher DM, Pegelow CH, Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000;22(4):335–339.
  • Hulbert ML, McKinstry RC, Lacey JL, Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood. 2011;117(3):772–779.
  • Casella JF, King AA, Barton B, Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol. 2010;27(2):69–89.
  • Wang WC. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol. 2007;14(3):191–197.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.